Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

If you’re just plain tired of expensive cell phone contracts but still want to own a high quality, beautifully-styled smartphone that can do a million and one things, then you’re invited to join Elizabeth Little, Director of Marketing for iRULU Technologies. Discover as Elizabeth demonstrates how you can own a gorgeous smartphone with all the bells-and-whistles you could want that won’t cost an arm and a leg. iRULU smartphones and tablets feature today’s hottest digital technology, without the high price. iRULU offers a beautiful range of unlocked smartphones allowing customers to be free to change or cancel their service at any time.

Besides affordability, iRULU offers style. Their designers keep women’s needs in mind with special designs and many color choices. The smartphones are lightweight and ultra-thin. iRULU smartphones also provide a great feature for moms, Kid Mode. This allows moms to let their kids play with their smartphones without disrupting what was already there. Also, while you’re out and about capture moments with family and friends with a powerful built-in camera and a bright vivid display.
Make sure to check out the iRULU Universe Family for only $99 or maybe the iRULU Victory Family at $129 will be a better fit. Don’t forget to take 20% off using promo code TBA20 on iRULU.com

With beauty and functionality – the iRULU Victory and Universe smartphones – will delight even the most demanding technology lover, without breaking the bank. It’s technology without the tradeoffs.

Watch The Balancing Act…weekdays on Lifetime Television. Check your local cable listings for day and channel.

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.

Comments

comments